ZipBio
Seattle
About ZipBio
ZipBio focuses on compressing biology to develop the next generation of gene therapies. The company leverages machine learning, protein engineering, and molecular materials to create innovative therapeutic solutions. As a biotechnology firm, ZipBio aims to advance the field of synthetic biology and self-assembly techniques to address complex medical challenges.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $4.0M
- Funding stage: Seed
- Last round: Seed (Sep 2024)
- Website: ziptx.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/zipbio-129471 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.